Enhancing Clinical Research through Strategic Partnerships
In a significant development for the life sciences community, BioIVT LLC has entered into an exclusive commercial agreement with KRISHGEN BioSystems. This collaboration aims to significantly enhance clinical research capabilities in South Asia. BioIVT, renowned for its biospecimen solutions and global research partnerships, brings high-quality products vital for drug and diagnostic development. Meanwhile, KRISHGEN BioSystems contributes its extensive expertise and established presence in the region.
Exclusive Representation of BioIVT’s Product Portfolio
Access to Essential Biological Materials
Through this exclusive agreement, KRISHGEN BioSystems has secured the rights to represent BioIVT’s extensive range of biological materials, which includes biofluids, tissues, cellular products, and various enzymatic components. This diverse portfolio is indispensable for various research fields such as drug discovery, development, and personalized medicine. Researchers in India, Bangladesh, and Nepal will benefit from rapid access, competitive pricing, and continuous technical support.
Benefits of the Collaboration
Improving Research Efficiency
The partnership is set to not only enhance the speed at which researchers receive the necessary materials but also improve overall research efficiency. BioIVT’s Director of Global Channel Partnerships, Dimas Neto, expressed confidence that this agreement will greatly elevate life sciences research in the region. The goal is to foster scientific discoveries which can ultimately transform healthcare and lead to better patient outcomes.
Commitment to Quality in Life Sciences
Shared Goals with KRISHGEN BioSystems
KRISHGEN BioSystems has been a prominent player in life science research tools and services in the South Asian region for over two decades. Their VP of International Business Development, Krisha Jain, emphasized the shared commitment between the two organizations to deliver the highest quality biological materials. This alignment of goals has been fundamental in enhancing their collaborative efforts.
About BioIVT
BioIVT is dedicated to enabling smarter science and accelerating medical breakthroughs. They provide high-quality personalized biospecimen solutions tailored for the life sciences and diagnostic industries. The company specializes in various samples, including both human and animal tissues, as well as products for ADME-Tox and other research applications. Their comprehensive portfolio directly supports precision medicine initiatives aimed at improving patient outcomes.
About KRISHGEN BioSystems
KRISHGEN BioSystems emphasizes delivering quality tools to scientists, armed with a strong background in immunology. As a certified and accredited biotech company, they offer unique assays and reagents to support the life sciences research community. Their academic links enable them to stay at the forefront of scientific advancement, providing innovative solutions that drive research forward.
Frequently Asked Questions
What is the focus of the agreement between BioIVT and KRISHGEN BioSystems?
The agreement focuses on enhancing clinical research capabilities in South Asia by providing access to high-quality biological materials and support.
What kind of products will KRISHGEN BioSystems represent?
KRISHGEN BioSystems will exclusively represent BioIVT’s comprehensive portfolio of biofluids, tissues, cell products, and enzymes.
How will this partnership benefit researchers?
This partnership will provide researchers with faster access to materials, competitive pricing, and ongoing technical support, enhancing their overall research experience.
What are BioIVT's core services?
BioIVT specializes in delivering high-quality biospecimen solutions for the life sciences and diagnostic industries, focusing on control and disease state samples.
How long has KRISHGEN BioSystems been in the life sciences field?
KRISHGEN BioSystems has over two decades of experience in providing life science research tools and services across South Asia.
